Author Archives: akshayjadhav0912

Non Invasive Prenatal Testing Market: Market Insights and Market Potential

According to the new market research report Non-Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) – Global Forecast to 2021, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia, and the Rest of the World (RoW).

Don’t miss out on business opportunities in “Non Invasive Prenatal Testing Market”. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2DgGbjd

Early buyers will receive 10% customization on reports.

The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016 at a CAGR of 16.4% during the forecast period. The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.

Market Dynamics

Drivers

  • High risk of chromosomal abnormalities with increasing maternal age
  • Growing preference for non-invasive techniques over invasive methods
  • Launch of new and advanced products
  • Improving reimbursement scenario for NIPT
  • Programs focusing on increasing the awareness of NIPT

Restraints

  • Lack of skilled professionals

Opportunities

  • Untapped emerging markets

Challenges

  • Reliability of test results especially in obese women

High risk of chromosomal abnormalities with increasing maternal age is a major driver for the market

Maternal age refers to the age of women at the time of delivery. Advancing maternal age can result in a number of health complications, such as decreased fertility and high blood pressure, and increase in the risk of miscarriage, stillbirths, and maternal death. Moreover, advancing maternal age can increase the risk of genetic disorders in babies as a result of the improper chromosomal division. The resulting abnormalities in babies may include microcephaly; short neck; upward slanted eyes; poor muscle tone; heart, intestine, and breathing problems; and other issues.

The impact of this factor is expected to increase across the globe as a result of the increase in average age of first-time mothers. Some of the important statistics in this regard have been mentioned below:

  • In the U.S., around 10% of babies were born to first-time mothers at the age of 35 years or older, in 2016. Also, the median age of first-time mothers increased from 24.9 years in 2000 to 26.3 years in 2014 in the country (Source: CDC).
  • According to Eurostat, in 2013, around 40.6% of women in the European Union who gave birth to their first child belonged to the age group of 30 years and above. Also, in the same year, around 65,500 births of first children were reported in women aged more than 40 years.
  • According to Statistics Canada, in 2013, approximately 43% of births in the country were reported in women belonging to the age group of 30 to 49 years; in 1993, only 26% births were reported in women belonging to the same age group.
  • In Australia, the average age of first-time mothers increased from 27.8 years in 2003 to 28.6 years in 2013 (Source: Australian Bureau of Statistics, 2015).

In order to detect genetic abnormalities resulting from improper chromosomal division, there is a growing demand for developing advanced and effective diagnostic procedures for early screening. Non-invasive prenatal testing is one such upcoming field which utilizes cell-free DNA in maternal plasma/fetal cells in maternal blood to determine genetic abnormalities. Thus, with the growing incidence of chromosomal abnormalities and benefits offered by NIPT, the demand for these tests is expected to increase in the coming years.

Browse and in-depth TOC on “Non Invasive Prenatal Testing Market

110 – Tables

48 – Figures

150 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

The NIPT market is competitive in nature, with several major players competing for market space. Some of the prominent players in the market include  Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pacific Biosciences of California, Inc. (U.S.), PerkinElmer, Inc. (U.S.), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (U.S.), Beijing Genomics Institute (China), GE Healthcare (U.S.), and Koninklijke Philips N.V. (Netherlands).

Major Market Developments:

  • In January 2017, Pacific Biosciences California, Inc. signed an agreement to supply Novogene Corporation, a provider of genomic and bioinformatics solutions, with ten sequel Systems for whole genome sequencing, Iso-sequence annotation, and target sequencing services
  • In November 2016, GE Healthcare launched its ultrasound system—LOGIQ E9 XDclear 2.0 and showcased 25 new products at the Radiological Society of North America (RSNA) (U.S.). The showcased products included Senographe Pristina, SIGNA, DiscoveryMI and GSI Xtream on Revolution CT2, OptimaXR240amx, and other digital and software technologies. These products offer improved performance, productivity, and better clinical outcomes for clinicians and hospitals worldwide.
  • In March 2016, Thermo Fisher Scientific acquired Affymetrix, Inc. (U.S.), a leading provider of life science and molecular diagnostic products. This acquisition enabled the company to strengthen its bioscience and genetic analysis capabilities.

Request for Free Sample Report @ http://bit.ly/2T6mr7p

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/non-invasive-prenatal-testing-market.asp

Visit Our Website: https://www.marketsandmarkets.com

High Content Screening Market: Business Growth, Development Factors, Application and Future Prospects

According to the new market research report High Content Screening Market by Product (Cell Imaging & Analysis System, Flow Cytometry, Consumable, Software, Service) Application (Primary & Secondary Screening, Toxicity Studies, Target Identification & Validation), End User – Global Forecast to 2022, published by MarketsandMarkets™,The global high-content screening market is expected to reach USD 909.0 Million by 2022 from USD 557.1 Million in 2017, at a CAGR of 10.3%.

Don’t miss out on business opportunities in High Content Screening Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2z3G8oc

Early buyers will receive 10% customization on reports.

The conventional method of toxicity studies involves the screening of large libraries in search of potential drug candidates. This method is expensive, resource- & time-consuming, and has a low success rate. Hence, HCS solutions for testing the potential toxicity of chemicals and complex substances are being adopted by pharmaceutical companies to improve in vitro toxicity testing by reducing the time and cost. The need for cost containment in pharma R&D, advancements in informatics solutions and imaging instruments, and government funding and venture capital investments across developed markets are the major factors driving the growth of the high-content screening (HCS) market.  The increasing number of contract research organizations providing HCS outsourcing services, and application of HCS in personalized medicine, present significant growth opportunities in the market. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

Market Dynamics

Drivers

  • Need for cost containment in pharma R&D
  • Government funding and venture capital investments across developed markets
  • Advancements in informatics solutions and imaging instruments

Restraint

  • Lower adoption of HCS instruments due to their high prices

Opportunities

  • Increasing number of CROs providing HCS services
  • Application of HCS in personalized medicine

Challenges

  • Dearth of knowledgeable and skilled operators of HCS instruments
  • Inadequate infrastructure and funding for R&D in emerging countries

Advancements in informatics solutions and imaging instruments drives the global high content screening market

Over the last few years, the HCS market has witnessed significant developments in the quality of cell imaging instruments and imaging analysis solutions. For instance, the Cell Insight CX7 high-content analysis platform, launched by Thermo Fisher Scientific, Inc. in January 2016, is an integration of wide-field and confocal imaging that enables seven-color excitation and laser autofocus. Moreover, various cell analyzers and cell sorters have also been introduced in the market. In December 2015, Becton, Dickinson and Company launched the BD FACSCelesta cell analyzer that offers the simultaneous measurement of up to 14 different single-cell characteristics. These technologically advanced products have enabled researchers to carry out cell image analysis with increased efficiency and reduced costs.

Browse and in-depth TOC on “High Content Screening Market

138 – Tables

42 – Figures

166 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html

The HCS market is highly competitive in nature. The prominent players in the global high-content screening market are GE Healthcare (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Tecan Group (Switzerland), BioTek Instruments Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.).

Request for Free Sample Report @ http://bit.ly/2PVTMDg

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/high-content-screening-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Computer Assisted Coding Market worth $4.75 Billion by 2022

According to the new market research report Computer Assisted Coding Market by Software (Natural Language Processing, Structured Input, Integrated Systems), Service (Support, Education & Training), Application (Automated Encoding, Clinical Coding Audit, Management Reporting) – Global Forecast to 2022, published by MarketsandMarkets™, The global computer-assisted coding market is valued at USD 2.76 Billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 Billion by 2022.

Don’t miss out on business opportunities in Computer Assisted Coding Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2B0JPMx

Factors driving market growth include the growing need within the global healthcare system to curtail increasing healthcare costs, improve coding accuracy, and streamline the revenue process. In addition, the eventual conversion from ICD-9 to ICD-10 is slated to increase the number and complexity of medical codes. This is expected to result in an exponential increase in the volume of structured clinical documentation, thereby, increasing the demand for CAC solutions to manage this data. The increasing consolidation among healthcare providers, increasing consolidation among the players operating in the computer-assisted coding market and evolution of new coding technology for computer-assisted coding in the U.S are the key trends in the computer-assisted coding market.

By product and service, the CAC solutions segment accounted for the largest share of the market in 2016

On the basis of product and service, the market is categorized into solutions and services. The solutions segment is further divided into standalone and integrated software. The standalone computer-assisted coding software considered is of two types natural language processing (NLP) software and structured input software. Similarly, the services segment is divided into support & maintenance and education & training services. In 2016, the CAC solutions segment accounted for the largest share of the computer-assisted coding market. The large share can be attributed to the need to shift from ICD-9 to ICD-10 coding standards, government initiatives for eHealth, and the rising need to adhere to regulatory requirements.

By mode of delivery, the cloud-based solutions is expected to grow at the highest CAGR

By mode of delivery, the global computer-assisted coding market is segmented into web-based solutions, cloud-based solutions, and on-premise solutions. In 2016, the cloud-based solutions segment dominated the global computer-assisted coding market. This growth can be attributed to the advantage of its flexible, scalable, and affordable nature and additional advantage of a separate cloud for the client along with a public cloud server and easy access to information for users operating in different time zones and geographic locations.

By application, the automated computer-assisted encoding segment is projected to grow at the highest CAGR during the forecast period

Based on application, the market is categorized into three types automated computer-assisted encoding, anagement reporting and analytics, and clinical code auditing. The automated computer-assisted encoding application is expected to grow at the highest CAGR during the forecast period. This can be attributed to the rise in the volume of patient data and codes processed, rising adoption of electronic health records, and the need to conform to the ICD-10 standards.

By end users, the hospitals segment held the largest market share in 2016

The major end users of computer-assisted coding are hospitals, physicians’ practices, clinical laboratories, academic medical centers, and other healthcare institutions. In 2016, the hospitals segment accounted for the largest share of the global computer-assisted coding market. The high growth rate of the hospitals segment can be primarily attributed to the successful and high adoption of computer-assisted coding to curtail healthcare delivery costs while maintaining compliance.

Browse and in-depth TOC on “ Computer Assisted Coding Market “

202 – Tables

40 – Figures

242 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/computer-assisted-coding-market-170644018.html

North America dominated the market in 2016

In 2016, North America dominated the global computer-assisted coding market. Increasing government support for improving healthcare infrastructure, growing need for reducing healthcare costs, and advancements in healthcare facilities are driving the growth of the computer-assisted coding market in this region.

The key players in the computer-assisted coding market are 3M Health Information Systems (U.S.), Optum, Inc. (U.S.), Nuance Communications, Inc. (U.S.), McKesson Corporation (U.S.), Cerner Corporation (U.S.), Dolbey Systems, Inc. (U.S.), Precyse Solutions, LLC (U.S.), Craneware plc (U.K.), Artificial Medical Intelligence (U.S.), and TruCode (U.S.).

Request for Free Sample Report @ http://bit.ly/2JWjhPB

Browse Adjacent Markets @ Healthcare IT Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: mailto:sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/computer-assisted-coding-market.asp

Visit Our Website: https://www.marketsandmarkets.com/

Gas Chromatography Market: Market Insights, Market Potential with New Applications

According to the new market research report Gas Chromatography Market by Instrument (Systems, Detectors), Accessories and Consumables (Columns, Column accessories, Pressure regulators, Gas generators),End user (Oil & Gas industry, Environmental agencies, Pharma & Biotech) – Global Forecast to 2022″, published by MarketsandMarkets™, The global gas chromatography market is expected to reach USD 3.67 Billion by 2022 from USD 2.64 Billion in 2016, at a CAGR of 6.2%.

Don’t miss out on business opportunities in Gas Chromatography Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2JXlLNE

The overall gas chromatography market is expected to reach USD 3671.0 million by 2022 from USD 2647.0 million in 2016, at a CAGR of 6.2%. The increasing crude & shale oil production, increasing importance of waste water treatment, rise in adoption of GC-MS, initiatives to reduce environmental pollution levels, growing food safety concerns and increased importance of chromatography tests in drug are the key factors driving the growth of this market. Owing to technological advancements, GC systems are witnessing a shift from laboratory settings to miniaturization, thus increasing their scope in production plants. Moreover, these advancements also increase the capabilities of gas chromatography in the analysis of complex compounds. For instance, the MicroGC Fusion is a small, easy to use, gas chromatograph (GC) specifically designed for gas analysis in the concentration range of low ppm to percentage levels.

Market Dynamics

Drivers

  • Increasing crude & shale oil production
  • Collaborations between chromatography instrument manufacturers and research laboratories/academic institutes
  • Increasing focus on waste water treatment
  • Rising adoption of GC-MS
  • Development of policies and initiatives to reduce environmental pollution levels
  • Growing food safety concerns
  • Growing importance of chromatography tests in the drug approval process

Restraints

  • High cost of gas chromatography equipment
  • Geopolitical issues prevailing in some countries

Opportunities

  • Improved gas chromatography columns for the petroleum industry
  • Potential new oilfield discovery
  • Growing proteomics market
  • Growing demand for chromatography instruments in emerging markets

Challenges

  • Dearth of skilled proffesionals

Increasing adoption of GC-MS drives the growth of the gas chromatography market

Considering the potential applications of GC-MS and the growing demand for the technique, major companies are focusing on launching GC-MS instruments in the market. For instance, in September 2014, Agilent Technologies, Inc. (U.S.) launched the 7200B Quadrupole Time of Flight (Q-TOF) Gas Chromatography Mass Spectrometer (GC/MS). This system offered improved mass accuracy and stability with a focus on pesticide screening software tools. This has resulted in increased application of GC-MS instruments in the field of biotechnology.

Browse and in-depth TOC on “ Gas Chromatography Market

86 – Tables

31 – Figures

161 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/gas-chromatography-market-101656773.html

The gas chromatography market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Major players in the market are Agilent Technologies, Inc.(U.S), Shimadzu Corporation(Japan), Thermo Fisher Scientific, Inc.  (U.S.), and PerkinElmer, Inc.(U.S.).

Request for Free Sample Report @ http://bit.ly/2JXlR7Y

Browse Adjacent Markets @ Analytical and Scientific Instrumentation Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/gas-chromatography-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Track etched Membrane Market worth $813.1 million by 2023

According to the new market research report Track etched Membrane Market by Product (Membrane Filter, Capsule & Cartridge Filter, Cell Culture Insert), Material (Polycarbonate, Polyimide), Application (Cell Biology, Microbiology, Analytical testing, Automotive), End User – Global Forecast to 2023, published by MarketsandMarkets™, The track etched membrane market is expected to reach USD 813.1 million by 2023 from USD 476.0 million in 2018, at a CAGR of 11.3% from 2018 to 2023. The growth of the pharmaceutical R&D expenditure is expected to be one of the major factors driving the growth of this market during the forecast period. Moreover, the collaborative application of nanotechnology and track etching is expected to increase the adoption of track etched membranes in various applications, such as healthcare, fuel cells, telecommunications, and transportation.

Don’t miss out on business opportunities in Track etched Membrane Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2SRoJr2

Early buyers will receive 10% customization on reports.

[140 Pages Report] The track etched membrane market was valued at 428.4 million in 2017 and is projected to grow at a CAGR of 11.3% during the forecast period, to reach to USD 813.1 million by 2023. The base year considered for the report is 2017 and the forecast period is from 2018 to 2023.

Objectives of the study

  • To define, describe, segment, and forecast the global track etched membrane market by product, material, application, end user, and region
  • To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the track etched membrane market in North America, Europe, Asia Pacific, and the Rest of the World
  • To profile key players in the track etched membrane market and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; mergers & acquisitions; and product developments and launches undertaken by key players in the track etched membrane market

Browse and in-depth TOC on “Track etched Membrane Market

85 – Tables

37 – Figures

140 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/track-etched-membrane-market-42556211.html

Geographically, the global track etched membrane market is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to continue to dominate the track etched membrane market till 2023, followed by Europe and Asia Pacific. The large share of the North American market can be attributed to the presence of global pharmaceutical manufacturers, a large number of quality control laboratories for the food & beverage industry, and growing concern towards improving the quality of food products and the medical devices that utilize track etched membranes.

Key players in the global track etched membrane are GE Healthcare (US), Danaher (US), Corning (US), Merck (Germany), it4ip (Belgium), Sterlitech (US), Oxyphen (Switzerland), Sarstedt (US), BRAND GMBH (Germany), Sartorius (Germany), SABEU (Germany), Zefon International (US), GVS (Italy), Thermo Fisher Scientific (US), Eaton (Ireland), Greiner Bio-One (Austria), MACHEREY-NAGEL (Germany), Avanti Lipids Polar (US), SKC (US), Advantec (Canada), Avestin (Canada), CHMLAB (Spain), Scaffdex (Finland), and Graver Technologies (US).

Request for Free Sample Report @ http://bit.ly/2RHjWHl

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/track-etched-membrane-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Vaccine Adjuvants Market Set for Rapid Growth and Trend by 2021

According to the new market research report Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category – Forecasts to 2021, published by MarketsandMarkets™, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the vaccine adjuvants market along with the estimates and forecasts of the revenue and market share analysis.

Don’t miss out on business opportunities in “Vaccine Adjuvants Market”. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2qvuxcK

Early buyers will receive 10% customization on reports.

The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5% from 2016 to 2021. The major factors driving the growth of this market are high prevalence of infectious and zoonotic diseases, increasing focus on immunization programs by various government bodies, and growing focus on improved and long-lasting immunization against existing and emerging diseases.

The report segments this market into product type, route of administration, disease type, applications, and application categories. On the basis of product type, the vaccine adjuvants market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and others. Particulate adjuvants are expected to account for the largest share of the market. Adjuvant emulsions, on the other hand, are projected to grow at the highest CAGR from 2016 to 2021 due to factors such as the proven efficacy and relatively fewer safety issues involved in the use of adjuvant emulsions.

On the basis of route of administration, the vaccine adjuvants market is segmented into oral, subcutaneous, intranasal, intramuscular, intradermal, and others. The intramuscular segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. The rapidly growing geriatric population and increasing need for development of better vaccines for improved immunization are the key factors propelling the growth of this market.

On the basis of disease type, the vaccine adjuvants market includes infectious diseases, cancer, and other diseases. The infectious diseases segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. High incidences of diseases and research investments in life sciences are the major factors driving the growth of this market.

Based on applications, the global vaccine adjuvants market is segmented into research and commercial applications. Research applications are expected to account for the largest share of the market during the forecast period. Growth in this segment is driven by factors such as increasing need for better immunization for the increasing geriatric population and increasing government funding in research to meet the unmet needs for safe and effective vaccine adjuvants.

Browse and in-depth TOC on “Vaccine Adjuvants Market

90 – Tables

42 – Figures

156 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

On the basis of application categories, the vaccine adjuvants market is segmented into human and veterinary adjuvants. Adjuvants for humans are expected to account for the largest share of the global vaccine adjuvants market in 2016 and are expected to grow at a higher CAGR in the application category segment.

The key players in the vaccine adjuvants market include Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Request for Free Sample Report @ http://bit.ly/2qsX8zt

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/vaccine-adjuvants-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Bioinformatics Market: Market size and Market forecast by 2023

According to the new market research report Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) – Global Forecast to 2023, published by MarketsandMarkets™, The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.

Don’t miss out on business opportunities in “Bioinformatics Market”. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2yVIpBD

Early buyers will receive 10% customization on reports.

Based on product and service, the bioinformatics platforms segment is projected to grow at the highest CAGR in the market during the forecast period

On the basis of product & service, the market is broadly segmented into knowledge management tools, bioinformatics platforms, and services. The bioinformatics platform segment is projected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the increasing usage of different bioinformatics platforms in various genomic and proteomics applications. Additionally, there is an increase in the use of bioinformatics platforms in drug discovery and development, which also contributes to the growth of the market.

Based on applications, the genomics segment is estimated to account for the largest share of the market in 2018

On the basis of applications, the global bioinformatics market is divided into genomics, chemoinformatics and drug design, proteomics, transcriptomics, and metabolomics. In 2018, the genomics segment is expected to account for the largest share of the bioinformatics market. The rising application of genomics in personalized and preventive medicine is positively affecting market growth.

Browse and in-depth TOC on “Bioinformatics Market

189 – Tables

27 – Figures

195 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

North America is expected to dominate the market in 2018

Among the four geographic regions, North America is expected to account for the largest share of the bioinformatics market in 2018, followed by Europe, APAC, and the RoW. The large share of North America is attributed to the steady funding from the government and private sector for life sciences research and bioinformatics.

Market Players

The bioinformatics market is highly competitive due to the presence of a large number of players. Few of the major companies in bioinformatics market are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US), and DNASTAR (US).

Request for Free Sample Report @ http://bit.ly/2JGftBS

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/bioinformatics-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Anatomic Pathology Market: Business Growth, Development Factors, Application and Future Prospects by 2021

According to the new market research report Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) – Forecasts to 2021, published by MarketsandMarkets™, This report provides a detailed overview of the major drivers, restraints, challenges, opportunities, trends and strategies impacting the anatomic pathology market, along with revenue estimates & forecasts and market share analysis.

Don’t miss out on business opportunities in “Anatomic Pathology Market”. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2P4rMxV

The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021. The increasing prevalence of chronic diseases, growing aging population, and increasing healthcare expenditure are the major factors driving the growth of this market.

On the basis of product and service, the anatomic pathology market is segmented into instruments, consumables, and services. The instruments segment has been subsegmented into tissue processing systems, slides staining systems, microtomes, and other instruments. Similarly, the consumables segment has been subsegmented into reagents & antibodies, probes, kits, and other consumables. Likewise, the services segment has been subsegmented into cytopathology, histopathology, and other services. In 2016, the services segment accounted for the largest share of the market. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.

In the instrument subsegment, the tissue processing systems segment accounted for the largest share of the anatomic pathology market in 2016 due to the increasing automation in the instruments that improve the quality of diagnosis process. Similarly, in the consumables subsegment, the reagents & antibodies segment accounted for the largest share of the market, in 2016. This is due to increasing number of diagnostics tests that fuel the utilization of reagents & antibodies. Likewise, in the services subsegment, the histopathology segment accounted for the largest market share in 2016. This is mainly due to their use in the diagnosis of a wide range of chronic diseases, such as cancer, and bacterial and viral diseases.

On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and other applications. The disease diagnosis segment accounted for the largest market share in 2016. The rapid growth in the aging population and increasing incidence of cancer and other chronic diseases is a key market driver in this segment. The drug discovery & development segment accounted for the second largest share in 2016. Increasing R&D expenditure is driving the adoption of anatomic pathology services in pharmaceutical and biopharmaceutical companies for drug discovery & development applications.

Browse and in-depth TOC on “Anatomic Pathology Market

80 – Tables                         

32 – Figures

129 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/anatomic-pathology-market-137323145.html

On the basis of region, the global anatomic pathology market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Asia is expected to grow at the highest CAGR during the forecast period. The presence of emerging economies like China, India, and Japan; the large population and rising prevalence of chronic diseases in these countries; improving standards of living; growing demand for quality medical care; increasing healthcare spending and government initiatives; rising awareness about the use of anatomic pathology tests among physicians; and growth in the demand for diagnostics are some major factors driving the high growth of this regional segment.

Some of the major players operating in the anatomic pathology market are F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).

Request for Free Sample Report @ http://bit.ly/2yPeYBg

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com

IV Equipment Market outlook with industry review and forecasts – Global Forecast to 2022

According to the new market research report IV Equipment Market by Product (Infusion Pump, Catheter, Solution and Blood Administration Set, Securement Device, Cannula, Stopcock, Needleless Connector), End User (Hospitals & Clinics, Homecare, Ambulatory Care Center) – Global Forecast to 2022, published by MarketsandMarkets™, The global IV equipment market is expected to reach USD 13.63 Billion by 2022 from USD 10.07 Billion in 2017, at a CAGR of 6.2% from 2017 to 2022.

Don’t miss out on business opportunities in “IV Equipment Market”. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2yKK5xO

The major factors driving the growth of this market include increasing incidence of chronic diseases, rapid growth in the aging population, and growing number of surgical procedures. The high growth in developing countries across Asia-Pacific and Latin America are expected to provide significant growth opportunities for players operating in the IV equipment market in the coming years. However, stringent regulatory requirements for new products and increasing incidence of medication errors and lack of wireless connectivity in most hospitals pose challenges for the growth of this market.

IV catheters to hold the largest market share during the forecast period

Based on product, the IV equipment market is segmented into IV catheters, administration sets, infusion pumps, securement devices, stopcocks & check valves, drip chambers, needleless connectors, and others. In 2016, the IV catheters accounted for the largest share of the market. Increasing prevalence of chronic diseases and the growing number of surgical procedures are the key factors driving the market growth in this segment.

Home care segment to grow at the highest CAGR during the forecast period

On the basis of end user, the market is classified into hospitals & clinics, home care, and ambulatory care centers. The home care segment is expected to grow at the highest CAGR during the forecast period. Factors propelling the growth of this segment include technological advancements and the increasing awareness and acceptance of home care devices.

Browse and in-depth TOC on “IV Equipment Market

102 – Tables

38 – Figures

166 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/iv-equipment-market-78345313.html

North America dominated the IV equipment market in 2016

In 2016, North America accounted for the largest share of the global IV equipment market, followed by Europe, Asia-Pacific, and RoW. This growth can be attributed to the rising geriatric population, increasing prevalence of chronic diseases, the presence of a well-established healthcare industry, growing demand for advanced medical treatments, the presence of major players, and increasing government healthcare expenditure.

Request for Free Sample Report @ http://bit.ly/2qnskQw

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1-888-600-6441

Email: sales@marketsandmarkets.com

Visit Our Website: https://www.marketsandmarkets.com

Glycobiology Market: Market potential, new applications, case-study

According to the new market research report Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User – Global Forecast to 2021, published by MarketsandMarkets™, The global glycomics/glycobiology market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3%. The market is segmented based on product, application, end user, and region.

Don’t miss out on business opportunities in Glycomics/Glycobiology Market. Speak to our analyst and gain crucial industry insights that will help your business grow: http://bit.ly/2NW9NEj

Early buyers will receive 10% customization on reports.

The global glycomics/glycobiology market is expected to reach USD 1,211.4 million by 2021 from USD 649.5 million in 2016, at a CAGR of 13.3%. Glycomics is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes. This study is used in diagnostics, drug discovery research, immunology, oncology, and various other applications. Glycomics products are widely used for analysis of cell surface markers, which can act as diagnostic or therapeutic targets. The base year considered for the study is 2015, and the forecast has been provided for the period between 2016 and 2021.

Market Dynamics

Drivers

  • Increasing funding for proteomics & glycomics research and growing R&D expenditure
  • Growth of the proteomics market
  • Technological advancements in glycomics instrumentation

Restraints

  • High degree of consolidation acts as an entry barrier for new entrants
  • Stringent regulatory frameworks and time-consuming approval processes

Opportunities

  • Increased use of personalized medicine
  • Biomarkers identification
  • Developing countries and emerging markets

Challenges

  • High cost of tools and instruments and their maintenance

Increasing funding for proteomics & glycomics research and growing R&D expenditure drives the global glycomics market

The growing demand for remedial treatments for life-threatening diseases, such as cancer, has driven the pace of pharmaceutical and biotechnological R&D as well as overall investments made in this sector. Both glycomics (being the study of glycans) and proteomics (being the study of proteins, and holding a prominent place in glycome R&D) are research-driven sectors. Moreover, glycomic biomarkers are finding significant applications in drug development and diagnostics for such diseases. As a result, the growing availability of funding for these two sectors is expected to aid the growth of the glycomics market, in the coming years.

Browse and in-depth TOC on “Glycomics/Glycobiology Market

91 – Tables

32 – Figures

158 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/glycobiology-market-132685525.html

The key players in the glycomics/glycobiology market include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.).

Request for Free Sample Report @ http://bit.ly/2PdMCdb

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/glycobiology-market.asp

Visit Our Website: https://www.marketsandmarkets.com